Drawing for SYNAPSE MED

USPTO serial 97065557

SYNAPSE MED

Reviewed by CopyMark Law Group

Reg. 7874118Status 700Registered
Filing date
Status date
Registration date
Jul 29, 2025
Examiner
LE, KIEU-NHI NGOC
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNAPSE MED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Denys

Todd A. Denys Mandelbaum Barrett PC3 Becker Farm Road, Suite 105Roseland, NJ 07068United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software using artificial intelligence for medical prescription assistance, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence to avoid medical risks and contraindications and for drug interaction prevention, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysis, namely, software for word processing and establishing standardized directories; none of the above products are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical fieldACTIVE—
042Research in the field of artificial intelligence for computer software design for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Research in the field of artificial intelligence for computer software design for prescription analysis; Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software design and development for prescription analysis; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories in the fields of medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories for prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field; Software as a service (SAAS) services featuring software modules for providing prescription assistance through telemedicine platformsACTIVE—
044Telemedicine services; Prescription assistance modules in the nature of providing information in the field of medical prescriptions via telemedicine platforms; Providing advice relating to medical services provided via telecommunications technology; providing information in the field of telemedicine; providing information in the field of medical prescription; providing information in the field of medical prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 29, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 16, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 16, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 16, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 16, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 7, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 7, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 3, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 10, 2025IUAFUSE AMENDMENT FILED—
Mar 10, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 10, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 11, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jun 7, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 7, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 7, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 6, 2024ALIEASSIGNED TO LIE—
Apr 17, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 17, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 17, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 17, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 17, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 14, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 14, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 14, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 14, 2023CNSISUSPENSION INQUIRY WRITTEN—
Feb 16, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 16, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Feb 16, 2023CNSLSUSPENSION LETTER WRITTEN—
Jan 17, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 16, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2022DOCKASSIGNED TO EXAMINER—
Nov 1, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 12, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance